Posts Tagged ‘Baycol’
America’s Healthcare Crisis–Part II–What Do We Get for $$$ ?
Part II. What Do We Get for All That Money? A preventable epidemic of injury and death from prescription drugs; FDA’s contribution to the epidemic; Big Pharma’s business model: manufactured myths, propaganda and a hidden agenda;
US Healthcare Third Leading Cause of Death_Barbara Starfield, MD
Why didn’t Barbara Starfield’s Findings (JAMA 2000) cause a major overhaul of US medicine?
Read More
Rx Drugs Recalled for Safety Issues from US market
List of FDA-licensed prescription drugs withdrawn from US market for safety issues:
Between 1973 and 1991 (18 years) —16 drugs were withdrawan; Between 1992 and 2011 (19 years)—28 drugs were withdrawn.
Lies, Damned Lies, and Medical Science
A fascinating article in The Atlantic, "Lies, Damned Lies, and Medical Science" by David Freedman, profiles Dr. John Ioannidis, who says that as much as 90% of the published medical information that doctors rely on is flawed.
Read MoreFDA Approves Crestor Use for Healthy People–Watch Healthcare Costs Skyrocket
"500 people would need to be treated with Crestor for a year to avoid one usually survivable heart attack. Stroke numbers were similar…At $3.50 a pill, the cost of prescribing Crestor to 500 people for a year would be $638,000 to prevent one heart attack."
Read MoreBayer Settles Baycol AG Stuits $8 million
Repeat legal violations: The record of recidivism by major drug manufacturers is a matter of public record.
Read MoreRole of Litigation in Defining Drug Risks_JAMA / BMJ
Documents uncovered during the course of litigation shed light on real risks of drug-induced harm that would not otherwise be known.
Read MoreDangerous Deception: Hiding the Evidence of Adverse Drug Effects_NEJM
FDA's slip-shod approval of defective, harmful drugs, accompanied by rubber stampped endorsements by compromised FDA advisory committees may be reaching a boiling point.
Read MoreFDA Rejects Crestor Petition–Sacrificing Patient safety
FDA Rejects Crestor Petition–Sacrificing Patient safety Tue, 15 Mar 2005 The FDA’s safety standard for allowing a drug to be marketed has been turned on its head. The law requires that a manufacturer provide scientific proof that a drug is safe and effective before it can be licensed for marketing. The FDA has shifted the…
Read MoreCholesterol lowering drug, Crestor Linked to Patient Death
Cholesterol lowering drug, Crestor Linked to Patient Death Tue, 11 Jan 2005 Crestor, a highly advertised cholesterol-lowering drug in the statin class–as was Bayer’s drug Baycol, which was withdrawn from market after 30 patients died of rhabdomyolysis (breakdown of skeletal muscle fibers), has been linked to a patient’s death. “AstraZeneca confirms that a death possibly…
Read MorePublic Servant or Private Marketer? NIH Seeks Inquiry of Alzheimer’s researcher conflicts of interest
NIH: Public Servant or Private Marketer? NIH Seeks Outside Inquiry of Alzheimer’s researcher conflicts of interest – LAT Mon, 31 Jan 2005 A year after the Los Angeles Times published its first an in-depth investigative report documenting in detail evidence of major conflicts of interest by top scientists at the National Institutes of Health, [December…
Read MoreBayer/ Baycol on Trial in Texas – NYT
Bayer/ Baycol on Trial in Texas_NYT Sat, 1 Mar 2003 Melody Peterson of the New York Times reports that in the first case brought against Bayer involving its anticholesterol drug, Baycol, a senior official of Bayer AG testified in court in Corpus Cristi, Texas. He acknowledged that company officials in Germany proceeded with the marketing…
Read More